HCW Biologics Inc. (HCWB) vs 60 Degrees Pharmaceuticals Inc. (SXTP)

HCW Biologics Inc. and 60 Degrees Pharmaceuticals Inc. are both Biotechnology companies. HCW Biologics Inc. and 60 Degrees Pharmaceuticals Inc. are of similar size ($4.2M and $4.1M). HCW Biologics Inc. grew revenue faster over the last twelve months: 707.0% against 23.4%. HCW Biologics Inc. has the higher net margin (−329.4% vs −650.3%) and the higher return on invested capital (−36.2% vs −348.6%). Across the 16 metrics below, HCW Biologics Inc. leads on 10 and 60 Degrees Pharmaceuticals Inc. on 6.

Valuation

Metric HCWB SXTP Biotechnology median
P/E n/m n/m 7.88
P/S 0.38 2.56 11.47
P/B 0.35 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.30 1.84 10.73
Earnings yield (1,429.91%) (185.50%) (28.84%)
Free cash flow yield (483.74%) (291.87%) (23.03%)

Profitability

Metric HCWB SXTP Biotechnology median
Gross margin 95.91% 43.42% 65.16%
Operating margin (114.02%) (691.33%) 0.00%
Net margin (329.38%) (650.34%) 0.00%
Free cash flow margin (180.57%) (745.93%) 0.00%
Return on equity (600.32%) 110.82% (57.72%)
Return on assets (79.52%) (186.70%) (49.22%)
Return on invested capital (36.15%) (348.64%) 0.00%

Growth

Metric HCWB SXTP Biotechnology median
Revenue growth (TTM) 706.96% 23.41% 5.64%
EPS growth (last fiscal year) 65.49% 84.19% —
Revenue growth, 5-year CAGR — (11.18%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HCWB SXTP Biotechnology median
Debt to equity 0.88 0.00 0.00
Current ratio 0.06 2.32 4.73
Net debt to EBITDA (0.40) 0.37 0.96

Dividend

Metric HCWB SXTP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric HCWB SXTP Biotechnology median
Market cap 4.18m 4.08m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack